智通财经APP获悉，里昂发布研报称，中国处方药带动今年中国线上药房收入加快增长。京东健康(06618)指引，今年收入和经调整净利润同比各增长约20%和15%，而阿里健康(00241)则指引明年3月底止2026财年的收入和经调整净利润同比分别增长10至15%及20至30%。该行表示，随着下半年原厂药销售持续强劲，相信盈利有上行空间。虽然大部分零售类别已实现高线上渗透率，但药品在线上有最大增长潜力。
智通财经APP获悉，里昂发布研报称，中国处方药带动今年中国线上药房收入加快增长。京东健康(06618)指引，今年收入和经调整净利润同比各增长约20%和15%，而阿里健康(00241)则指引明年3月底止2026财年的收入和经调整净利润同比分别增长10至15%及20至30%。该行表示，随着下半年原厂药销售持续强劲，相信盈利有上行空间。虽然大部分零售类别已实现高线上渗透率，但药品在线上有最大增长潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.